Brind.

Exagen Inc. and Cencora Complete Stock Exchange Listings

2 reports, 2 independent Updated Mon 00:00
No new developments lately
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Exagen Inc. successfully listed on the Nasdaq stock exchange on September 1, 2026. Concurrently, Cencora completed its listing on the NYSE stock exchange on the same date.

From themarketsdaily.com

Why it matters

Some supportBrind's analysis of the reports

The listings provide these healthcare companies with access to major capital markets. This market presence allows investors to trade shares of both Exagen Inc. and Cencora.

From themarketsdaily.com

Who's involved

  • Exagen Inc.Clinical laboratory company listed on the Nasdaq stock exchange
  • CencoraUS drug wholesale company listed on the NYSE stock exchange

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped